MA50669A - Nouveaux sels - Google Patents
Nouveaux selsInfo
- Publication number
- MA50669A MA50669A MA050669A MA50669A MA50669A MA 50669 A MA50669 A MA 50669A MA 050669 A MA050669 A MA 050669A MA 50669 A MA50669 A MA 50669A MA 50669 A MA50669 A MA 50669A
- Authority
- MA
- Morocco
- Prior art keywords
- new salts
- salts
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762564744P | 2017-09-28 | 2017-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA50669A true MA50669A (fr) | 2020-08-05 |
Family
ID=65902742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA050669A MA50669A (fr) | 2017-09-28 | 2018-09-28 | Nouveaux sels |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20200255438A1 (fr) |
| EP (1) | EP3687533A4 (fr) |
| JP (1) | JP2020536070A (fr) |
| KR (1) | KR20200060404A (fr) |
| CN (1) | CN111343978A (fr) |
| AU (2) | AU2018338884A1 (fr) |
| BR (1) | BR112020005992A2 (fr) |
| CA (1) | CA3074923A1 (fr) |
| EA (1) | EA202090853A1 (fr) |
| IL (1) | IL273520A (fr) |
| MA (1) | MA50669A (fr) |
| MX (1) | MX2020003741A (fr) |
| SG (1) | SG11202002200UA (fr) |
| WO (1) | WO2019067961A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200068678A (ko) | 2017-10-10 | 2020-06-15 | 바이오젠 인크. | 스피로 유도체를 제조하기 위한 공정 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2789711C (fr) * | 2010-02-17 | 2014-08-05 | Amgen Inc. | Derives d'arylcarboxamide en tant qu'inhibiteurs de canal sodique pour le traitement de la douleur |
| CA2867043A1 (fr) * | 2012-05-03 | 2013-11-07 | Novartis Ag | Sel de l-malate de derives de 2,7-diaza-spiro[4.5]dec-7-yle et ses formes cristallines a titre d'agonistes des recepteurs de ghreline |
| GB201209015D0 (en) * | 2012-05-22 | 2012-07-04 | Convergence Pharmaceuticals | Novel compounds |
-
2018
- 2018-09-28 EA EA202090853A patent/EA202090853A1/ru unknown
- 2018-09-28 BR BR112020005992-7A patent/BR112020005992A2/pt not_active Application Discontinuation
- 2018-09-28 CN CN201880063113.2A patent/CN111343978A/zh not_active Withdrawn
- 2018-09-28 CA CA3074923A patent/CA3074923A1/fr not_active Withdrawn
- 2018-09-28 WO PCT/US2018/053520 patent/WO2019067961A1/fr not_active Ceased
- 2018-09-28 JP JP2020518078A patent/JP2020536070A/ja not_active Withdrawn
- 2018-09-28 SG SG11202002200UA patent/SG11202002200UA/en unknown
- 2018-09-28 KR KR1020207009445A patent/KR20200060404A/ko not_active Withdrawn
- 2018-09-28 AU AU2018338884A patent/AU2018338884A1/en not_active Abandoned
- 2018-09-28 MA MA050669A patent/MA50669A/fr unknown
- 2018-09-28 MX MX2020003741A patent/MX2020003741A/es unknown
- 2018-09-28 EP EP18861356.6A patent/EP3687533A4/fr not_active Withdrawn
- 2018-09-28 US US16/651,577 patent/US20200255438A1/en not_active Abandoned
-
2020
- 2020-03-23 IL IL273520A patent/IL273520A/en unknown
-
2023
- 2023-04-13 AU AU2023202293A patent/AU2023202293A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023202293A1 (en) | 2023-05-11 |
| CN111343978A (zh) | 2020-06-26 |
| US20200255438A1 (en) | 2020-08-13 |
| IL273520A (en) | 2020-05-31 |
| EP3687533A1 (fr) | 2020-08-05 |
| EA202090853A1 (ru) | 2020-08-27 |
| BR112020005992A2 (pt) | 2020-09-29 |
| EP3687533A4 (fr) | 2021-01-20 |
| KR20200060404A (ko) | 2020-05-29 |
| MX2020003741A (es) | 2021-01-08 |
| SG11202002200UA (en) | 2020-04-29 |
| AU2018338884A1 (en) | 2020-04-16 |
| CA3074923A1 (fr) | 2019-04-04 |
| JP2020536070A (ja) | 2020-12-10 |
| WO2019067961A1 (fr) | 2019-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20220011I1 (fi) | Lumasiraani tai sen suola | |
| FIC20240005I1 (fi) | Elasestrantti tai sen suola | |
| EP3436455A4 (fr) | Nouveaux sels et cristaux | |
| HUE066592T2 (hu) | Bilincs | |
| MA50223A (fr) | Sels inhibiteurs de ferroportine | |
| DK3405050T3 (da) | Børnesikret snusbeholder | |
| MA44474A (fr) | Nouveaux inhibiteurs de la ferroportine | |
| LT3303334T (lt) | Tirozinkinazės inhibitoriai | |
| DK3442972T3 (da) | Bromdomænehæmmere | |
| EP3365371C0 (fr) | Agonistes de gitr | |
| EP3687535A4 (fr) | Nouveaux sels et cristaux | |
| EP3397705C0 (fr) | Revêtements à base d'eau forment une barrière | |
| DK3335532T3 (da) | Tandharve | |
| DK3402792T3 (da) | Quinolin-2-on-derivater | |
| DK3342949T3 (da) | Tagstruktur | |
| EP3383883A4 (fr) | Sels de conjugués en cancéro-thérapie | |
| MA46280A (fr) | Inhibiteurs de la dopamine-b-hydroxylase | |
| EP3425626A4 (fr) | Anche | |
| DK3481826T3 (da) | Tyrosinkinaseinhibitorer | |
| EP3489155A4 (fr) | Attache | |
| DE112017000734A5 (de) | Glycolsensor | |
| DE112017006386A5 (de) | Schraubarbeitszylinder | |
| DK3323708T3 (da) | Bovfender | |
| DK3317248T3 (da) | Sacubitrilcalciumsalte | |
| EP3347550A4 (fr) | Poteau |